{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7746,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/JY3nlhfhKhjvsk4UyXLBWfeRm8cRH82A9W6GwE1RZn4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMDc1NTc4MTlmODgxMGI1NzNkM2UyYTMxNzlhOWJhYy9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/1",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/s-YVUf0w2CAnpBvS1OpbhQ0BmL5o7xffj13LkP85ces/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMDc1NTc4MTlmODgxMGI1NzNkM2UyYTMxNzlhOWJhYy9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/QPrNNajgMlde6QulQzIRDQdKZLqMraOoq8eQMKvEXKg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMDc1NTc4MTlmODgxMGI1NzNkM2UyYTMxNzlhOWJhYy9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/jNCsOMz5c8hqocvOcQq_9OFF3dkswWXwt5QEmaSXutw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMDc1NTc4MTlmODgxMGI1NzNkM2UyYTMxNzlhOWJhYy9wMDAxLnBuZw"
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/2",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "agenda",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/3",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "team_bio",
      "function": "introduce_nominees",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/4",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "Includes AstraZeneca branding and a molecular visualization background.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/5",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "revenue_buildup",
      "function": "quantify_opportunity",
      "notes": "Uses a waterfall-bridge style to illustrate revenue growth drivers and headwinds.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/6",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "key_messages",
      "function": "present_solution",
      "notes": "The slide uses a structured grid to map high-level strategic goals to specific clinical assets.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/7",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "key_messages",
      "function": "present_framework",
      "notes": "The slide uses a three-pillar framework to describe the company's strategic approach to oncology.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/8",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "The slide uses a grid of cards to present clinical trial names, associated drugs, and key outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/9",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-9",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/10",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "The slide highlights high-impact clinical trial results presented at two major oncology conferences.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/11",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "The slide uses a three-row structure to categorize clinical and technological progress.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/12",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "Includes AstraZeneca branding and slide number 13.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/13",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "propose_solution",
      "function": "present_solution",
      "notes": "The slide uses a process diagram to illustrate the mechanism of action and a benefit-chain to explain the clinical advantages of the linker design.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/14",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide uses a checkmark/cross comparison matrix to demonstrate the superiority of QCS over IHC.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/15",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "The slide uses a process flow diagram to explain the computational pathology workflow.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/16",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes a Kaplan-Meier survival curve, a bar chart of prevalence by histology, and a Venn-style diagram illustrating the patient population selection process.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/17",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes two Kaplan-Meier plots with embedded summary tables for Non-squamous/non-AGA BEP and Overall BEP populations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/18",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "key_messages",
      "function": "present_framework",
      "notes": "The slide uses a matrix-like layout to map clinical trials to patient segments. The right-hand side provides a strategic summary of the trial program's design principles.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/19",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "Illustrates the transition from external lab processing to in-house diagnostic capabilities.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/20",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "The slide features a 3D rendering of an antibody molecule.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/21",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "problem_statement",
      "function": "diagnose_problem",
      "notes": "Includes references to clinical trials (CheckMate 274, AMBASSADOR, NIAGARA) and drug (Imfinzi).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/22",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-22",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 22,
          "from": 22,
          "beatId": "bd29e157-0501-4e1f-b25f-f2dd8dff4f68",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document highlights the high unmet need in muscle-invasive bladder cancer.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "Clinical trial design flow chart.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/23",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-23",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 25,
          "from": 23,
          "beatId": "ee40693e-a830-4773-906c-580d23182958",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document presents the design and baseline characteristics of the NIAGARA trial.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "The slide outlines a hierarchical testing strategy with alpha-exhaustive recycling and gatekeeping.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/24",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-24",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 25,
          "from": 23,
          "beatId": "ee40693e-a830-4773-906c-580d23182958",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document presents the design and baseline characteristics of the NIAGARA trial.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "comparison_table",
      "function": "summarize",
      "notes": "The slide presents clinical trial baseline data for two study arms.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/25",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-25",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 25,
          "from": 23,
          "beatId": "ee40693e-a830-4773-906c-580d23182958",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document presents the design and baseline characteristics of the NIAGARA trial.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "before_after",
      "function": "analyze_data",
      "notes": "Includes a table of clinical trial statistics (events, median EFS, HR, P-value) and a risk table.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/26",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-26",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 26,
          "beatId": "617689da-c69b-43c7-8222-b2a08def2699",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents the positive results of the NIAGARA trial.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "comparison_table",
      "function": "analyze_data",
      "notes": "Forest plot showing hazard ratios for Imfinzi vs comparator across clinical subgroups.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/27",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-27",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 26,
          "beatId": "617689da-c69b-43c7-8222-b2a08def2699",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents the positive results of the NIAGARA trial.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2e43-774b-aad6-58a03a29d59d",
      "docSlug": "207557819f8810b573d3e2a3179a9bac",
      "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 55 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "before_after",
      "function": "analyze_data",
      "notes": "Includes 'No. of patients at risk' table and statistical summary table.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2e43-774b-aad6-58a03a29d59d/28",
      "deckHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d",
      "deckAnchorHref": "/decks/019de077-2e43-774b-aad6-58a03a29d59d#slide-28",
      "loopMatches": [
        {
          "to": 35,
          "from": 22,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "e1d82b9f-ab34-4351-be54-5e9df327f1c4",
          "evidence": "The document highlights the high unmet need and presents NIAGARA as a solution.",
          "position": 0,
          "objective": "What is the cost of not addressing the unmet need in muscle-invasive bladder cancer?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 30,
          "from": 26,
          "beatId": "617689da-c69b-43c7-8222-b2a08def2699",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document presents the positive results of the NIAGARA trial.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2daa-712f-b521-c8c729e8485b",
      "docSlug": "57ae461a02ba3ab0a2dd5d5ece628a37",
      "documentTitle": "Talkspace | Results Presentation Deck | 11 slides",
      "authorId": "talkspace",
      "authorName": "Talkspace",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "appendix_disclosure",
      "function": "other",
      "notes": "Standard financial disclosure slide found in earnings presentations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2daa-712f-b521-c8c729e8485b/10",
      "deckHref": "/decks/019de077-2daa-712f-b521-c8c729e8485b",
      "deckAnchorHref": "/decks/019de077-2daa-712f-b521-c8c729e8485b#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 9,
          "beatId": "be24daf5-0cc7-4a2a-9463-9069f799d8a3",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "strong long-term growth plan and appendix provide next steps",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-2daa-712f-b521-c8c729e8485b",
      "docSlug": "57ae461a02ba3ab0a2dd5d5ece628a37",
      "documentTitle": "Talkspace | Results Presentation Deck | 11 slides",
      "authorId": "talkspace",
      "authorName": "Talkspace",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes footnotes explaining financial income and non-recurring expenses.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-2daa-712f-b521-c8c729e8485b/11",
      "deckHref": "/decks/019de077-2daa-712f-b521-c8c729e8485b",
      "deckAnchorHref": "/decks/019de077-2daa-712f-b521-c8c729e8485b#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 9,
          "beatId": "be24daf5-0cc7-4a2a-9463-9069f799d8a3",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "strong long-term growth plan and appendix provide next steps",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}